http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0055917-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D279-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D279-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate | 1981-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1984-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1984-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0055917-B1 |
| titleOfInvention | New benzothiazine derivatives, processes for preparation thereof and use thereof |
| abstract | Benzothiazine compounds having the general formula:- n<CHEM>n wherein R<1> is lower alkyl opt. substituted by carboxy, aryl and carboxy(lower)cycloalkyl; aryl opt. substituted by halogen, lower alkyl, halo(lower)alkyl and lower alkoxy; haloarylamino; or heterocyclic group;n R<2> is hydrogen, lower alkyl, lower alkylamino(lower)alkyl, aryl or ar(lower)alkyl;n R<3> is hydrogen, halogen, lower alkyl or lower alkoxy; andn n is 0, 1 or 2n their pharmaceutically acceptable salts are useful in the treatment of autoimmune diseases. |
| priorityDate | 1980-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 231.